IKT logo

Inhibikase Therapeutics (IKT) Interest Coverage Ratio

Annual Interest Coverage Ratio

N/A

31 December 2023

IKT Interest Coverage Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Coverage Ratio

N/A

30 September 2024

IKT Quarterly Interest Coverage Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IKT Interest Coverage Ratio Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

IKT Interest Coverage Ratio High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time

Inhibikase Therapeutics Interest Coverage Ratio History

DateAnnualQuarterly
Dec 2021
-742.02(+674.0%)
-25.21 K(+12.8%)
Sept 2021
-
-22.36 K(+6534.1%)
June 2021
-
-336.97(+51.5%)
Mar 2021
-
-222.48(+31.5%)
Dec 2020
-95.87
-169.13(+75.8%)
Sept 2020
-
-96.19(+83.6%)
DateAnnualQuarterly
June 2020
-
-52.39(-28.2%)
Mar 2020
-
-72.97(+33.1%)
Dec 2019
-229.76(+228.0%)
-54.84(-64.5%)
Sept 2019
-
-154.44(-63.0%)
June 2019
-
-417.61(-10.8%)
Mar 2019
-
-468.30
Dec 2018
-70.04
-

FAQ

  • What is the all time high annual interest coverage ratio for Inhibikase Therapeutics?
  • What is the all time high quarterly interest coverage ratio for Inhibikase Therapeutics?

What is the all time high annual interest coverage ratio for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high annual interest coverage ratio is -70.04

What is the all time high quarterly interest coverage ratio for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high quarterly interest coverage ratio is -52.39